Subrata Chakrabarti

Professor and Chair
Pathology
Western University
E-mail: Subrata.chakrabarti@lhsc.on.ca
Page: http://publish.uwo.ca/~schakrab/

Fields of interest: 

Chronic diabetic complications

 

Recent publications:

McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S.:
MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.
Diabetes, 60(4):1314-23 (2011)

Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S:
miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.
Diabetes, 60(11):2975-84 (2011)

Chen S, Feng B, George B, Chakrabarti R, Chen M, Chakrabarti S:
Transcriptional Co-activator p300 regulates Glucose Induced Gene Expression in the Endothelial Cells
Am J Physiol Endocrinol Metab., 298: E127-E137 (2010)

Feng B, Chen S, George B, Chakrabarti S:
miR133a regulates cardiomyocyte hypertrophy in diabetes.
Diabetes Metab Res Rev., 26:40-9 (2010)

Wu Y, Feng B, Chen S, Chakrabarti S:
ET-1 is regulated by Erk5 in diabetic retinopathy.
Canad. J. Physiol. Pharmacol., 88:607-615 (2010)

Wu Y, Zuo Y, Chakrabarti R, Feng B, Chen S, Chakrabarti S:
ERK5 contributes to VEGF alteration in diabetic retinopathy.
J. Ophthalmol., Article ID 465824, 2010

Chiu J., Khan ZA, Farhangkhoee H, Chakrabarti S:
Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor κB.
Nutrition, 25:964-72 (2009)